109960 — Aptocrom Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Aptocrom, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,416	9,598	16,007	16,400	9,807
Cost of Revenue
Gross Profit	1,762	2,130	4,981	5,365	1,478
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	11,092	10,528	20,180	15,433	18,615
Operating Profit	-2,675	-930	-4,173	967	-8,808
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,647	-5,261	5,578	-26,340	-6,426
Provision for Income Taxes
Net Income After Taxes	2,647	-5,607	4,171	-28,020	-5,634
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,650	-5,607	4,304	-28,094	-5,559
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	2,650	-5,607	1,851	-28,094	-5,559
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	76.3	-157	89.6	-246	-6.25
Dividends per Share